Filing Details

Accession Number:
0000200406-10-000091
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-21 16:31:06
Reporting Period:
2010-09-17
Filing Date:
2010-09-21
Accepted Time:
2010-09-21 16:31:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1142630 James Cullen Johnson &Amp; Johnson
One Johnson &Amp; Johnson Plaza
New Brunswick NJ 08933
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Disposition 2010-09-17 20,000 $61.35 26,022 No 4 S Direct
Common Disposition 2010-09-17 10,000 $61.35 20,000 No 4 S Indirect By Family LP and Family Foundation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Family LP and Family Foundation
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Phantom Stock Units $0.00 0 30,443 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
0 30,443 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $61.35 to $61.3703. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. Includes 745 shares held under Issuer's Dividend Reinvestment Plan.
  3. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
  4. The Phantom Stock Units held under the Issuer's Non-Employee Director Deferred Fee Planare to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time.
  5. 1 for 1